GL1X · GenesisL1 explorer

MolNFT v1 · #143080 · protein

Crystal structure of the A/BRISBANE/10/2007 (H3N2) influenza virus hemagglutinin apo form

6AOQ · Hemagglutinin HA1 chain: “Crystal structure of the A/BRISBANE/10/2007 (H3N2) influenza virus hemagglutinin apo form”. X-ray diffraction, 3 ligands (NAG, BMA, MAN), 2 pockets (best druggability 0.55). MolNFT v1 #143080 on GenesisL1…

PDB
6AOQ
Type
protein
Length
490 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin HA1 chain; Hemagglutinin HA2 chain
UniProt
A8W891
Ligands
NAG, BMA, MAN
Pockets
2 · best druggability 0.55

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHemagglutinin HA1 chainprotein31710% helix, 41% strandA8W891
BHemagglutinin HA2 chainprotein17351% helix, 15% strandA8W891

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 11 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12060.550.7936empty
2530.310.7615empty

Interfaces

1 interface between chains.

  • A–B · 3010 Ų buried · 44 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 glycan, 6 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6AOQ · Crystal structure of the A/Brisbane/10/2007 (H3N2) influenza virus hemagglutinin apo form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.